This report contains market size and forecasts of Companion Diagnostic Tests in Oncology in Global, including the following market information:
Global Companion Diagnostic Tests in Oncology Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Companion Diagnostic Tests in Oncology market was valued at 4012 million in 2020 and is projected to reach US$ 5682.3 million by 2027, at a CAGR of 9.1% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Companion Diagnostic Tests in Oncology companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Companion Diagnostic Tests in Oncology Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Companion Diagnostic Tests in Oncology Market Segment Percentages, By Type, 2020 (%)
Protein Detection
DNA Detection
China Companion Diagnostic Tests in Oncology Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Companion Diagnostic Tests in Oncology Market Segment Percentages, By Application, 2020 (%)
Pharmaceutical & Biotechnology Companies
Medical Device Companies
Research Institutes
Others
Global Companion Diagnostic Tests in Oncology Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Companion Diagnostic Tests in Oncology Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Total Companion Diagnostic Tests in Oncology Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Companion Diagnostic Tests in Oncology Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Abbott
Roche
Genomic Health
QIAGEN
Agilent
Agendia
BioMerieux
Illumina
Siemens Healthcare
Thermo Fisher
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Companion Diagnostic Tests in Oncology Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Companion Diagnostic Tests in Oncology Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Companion Diagnostic Tests in Oncology Overall Market Size
2.1 Global Companion Diagnostic Tests in Oncology Market Size: 2021 VS 2027
2.2 Global Companion Diagnostic Tests in Oncology Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Companion Diagnostic Tests in Oncology Players in Global Market
3.2 Top Global Companion Diagnostic Tests in Oncology Companies Ranked by Revenue
3.3 Global Companion Diagnostic Tests in Oncology Revenue by Companies
3.4 Top 3 and Top 5 Companion Diagnostic Tests in Oncology Companies in Global Market, by Revenue in 2020
3.5 Global Companies Companion Diagnostic Tests in Oncology Product Type
3.6 Tier 1, Tier 2 and Tier 3 Companion Diagnostic Tests in Oncology Players in Global Market
3.6.1 List of Global Tier 1 Companion Diagnostic Tests in Oncology Companies
3.6.2 List of Global Tier 2 and Tier 3 Companion Diagnostic Tests in Oncology Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Companion Diagnostic Tests in Oncology Market Size Markets, 2021 & 2027
4.1.2 Protein Detection
4.1.3 DNA Detection
4.2 By Type - Global Companion Diagnostic Tests in Oncology Revenue & Forecasts
4.2.1 By Type - Global Companion Diagnostic Tests in Oncology Revenue, 2016-2021
4.2.2 By Type - Global Companion Diagnostic Tests in Oncology Revenue, 2022-2027
4.2.3 By Type - Global Companion Diagnostic Tests in Oncology Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Companion Diagnostic Tests in Oncology Market Size, 2021 & 2027
5.1.2 Pharmaceutical & Biotechnology Companies
5.1.3 Medical Device Companies
5.1.4 Research Institutes
5.1.5 Others
5.2 By Application - Global Companion Diagnostic Tests in Oncology Revenue & Forecasts
5.2.1 By Application - Global Companion Diagnostic Tests in Oncology Revenue, 2016-2021
5.2.2 By Application - Global Companion Diagnostic Tests in Oncology Revenue, 2022-2027
5.2.3 By Application - Global Companion Diagnostic Tests in Oncology Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Companion Diagnostic Tests in Oncology Market Size, 2021 & 2027
6.2 By Region - Global Companion Diagnostic Tests in Oncology Revenue & Forecasts
6.2.1 By Region - Global Companion Diagnostic Tests in Oncology Revenue, 2016-2021
6.2.2 By Region - Global Companion Diagnostic Tests in Oncology Revenue, 2022-2027
6.2.3 By Region - Global Companion Diagnostic Tests in Oncology Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Companion Diagnostic Tests in Oncology Revenue, 2016-2027
6.3.2 US Companion Diagnostic Tests in Oncology Market Size, 2016-2027
6.3.3 Canada Companion Diagnostic Tests in Oncology Market Size, 2016-2027
6.3.4 Mexico Companion Diagnostic Tests in Oncology Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Companion Diagnostic Tests in Oncology Revenue, 2016-2027
6.4.2 Germany Companion Diagnostic Tests in Oncology Market Size, 2016-2027
6.4.3 France Companion Diagnostic Tests in Oncology Market Size, 2016-2027
6.4.4 U.K. Companion Diagnostic Tests in Oncology Market Size, 2016-2027
6.4.5 Italy Companion Diagnostic Tests in Oncology Market Size, 2016-2027
6.4.6 Russia Companion Diagnostic Tests in Oncology Market Size, 2016-2027
6.4.7 Nordic Countries Companion Diagnostic Tests in Oncology Market Size, 2016-2027
6.4.8 Benelux Companion Diagnostic Tests in Oncology Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Companion Diagnostic Tests in Oncology Revenue, 2016-2027
6.5.2 China Companion Diagnostic Tests in Oncology Market Size, 2016-2027
6.5.3 Japan Companion Diagnostic Tests in Oncology Market Size, 2016-2027
6.5.4 South Korea Companion Diagnostic Tests in Oncology Market Size, 2016-2027
6.5.5 Southeast Asia Companion Diagnostic Tests in Oncology Market Size, 2016-2027
6.5.6 India Companion Diagnostic Tests in Oncology Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Companion Diagnostic Tests in Oncology Revenue, 2016-2027
6.6.2 Brazil Companion Diagnostic Tests in Oncology Market Size, 2016-2027
6.6.3 Argentina Companion Diagnostic Tests in Oncology Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Companion Diagnostic Tests in Oncology Revenue, 2016-2027
6.7.2 Turkey Companion Diagnostic Tests in Oncology Market Size, 2016-2027
6.7.3 Israel Companion Diagnostic Tests in Oncology Market Size, 2016-2027
6.7.4 Saudi Arabia Companion Diagnostic Tests in Oncology Market Size, 2016-2027
6.7.5 UAE Companion Diagnostic Tests in Oncology Market Size, 2016-2027
7 Players Profiles
7.1 Abbott
7.1.1 Abbott Corporate Summary
7.1.2 Abbott Business Overview
7.1.3 Abbott Companion Diagnostic Tests in Oncology Major Product Offerings
7.1.4 Abbott Companion Diagnostic Tests in Oncology Revenue in Global (2016-2021)
7.1.5 Abbott Key News
7.2 Roche
7.2.1 Roche Corporate Summary
7.2.2 Roche Business Overview
7.2.3 Roche Companion Diagnostic Tests in Oncology Major Product Offerings
7.2.4 Roche Companion Diagnostic Tests in Oncology Revenue in Global (2016-2021)
7.2.5 Roche Key News
7.3 Genomic Health
7.3.1 Genomic Health Corporate Summary
7.3.2 Genomic Health Business Overview
7.3.3 Genomic Health Companion Diagnostic Tests in Oncology Major Product Offerings
7.3.4 Genomic Health Companion Diagnostic Tests in Oncology Revenue in Global (2016-2021)
7.3.5 Genomic Health Key News
7.4 QIAGEN
7.4.1 QIAGEN Corporate Summary
7.4.2 QIAGEN Business Overview
7.4.3 QIAGEN Companion Diagnostic Tests in Oncology Major Product Offerings
7.4.4 QIAGEN Companion Diagnostic Tests in Oncology Revenue in Global (2016-2021)
7.4.5 QIAGEN Key News
7.5 Agilent
7.5.1 Agilent Corporate Summary
7.5.2 Agilent Business Overview
7.5.3 Agilent Companion Diagnostic Tests in Oncology Major Product Offerings
7.5.4 Agilent Companion Diagnostic Tests in Oncology Revenue in Global (2016-2021)
7.5.5 Agilent Key News
7.6 Agendia
7.6.1 Agendia Corporate Summary
7.6.2 Agendia Business Overview
7.6.3 Agendia Companion Diagnostic Tests in Oncology Major Product Offerings
7.6.4 Agendia Companion Diagnostic Tests in Oncology Revenue in Global (2016-2021)
7.6.5 Agendia Key News
7.7 BioMerieux
7.7.1 BioMerieux Corporate Summary
7.7.2 BioMerieux Business Overview
7.7.3 BioMerieux Companion Diagnostic Tests in Oncology Major Product Offerings
7.4.4 BioMerieux Companion Diagnostic Tests in Oncology Revenue in Global (2016-2021)
7.7.5 BioMerieux Key News
7.8 Illumina
7.8.1 Illumina Corporate Summary
7.8.2 Illumina Business Overview
7.8.3 Illumina Companion Diagnostic Tests in Oncology Major Product Offerings
7.8.4 Illumina Companion Diagnostic Tests in Oncology Revenue in Global (2016-2021)
7.8.5 Illumina Key News
7.9 Siemens Healthcare
7.9.1 Siemens Healthcare Corporate Summary
7.9.2 Siemens Healthcare Business Overview
7.9.3 Siemens Healthcare Companion Diagnostic Tests in Oncology Major Product Offerings
7.9.4 Siemens Healthcare Companion Diagnostic Tests in Oncology Revenue in Global (2016-2021)
7.9.5 Siemens Healthcare Key News
7.10 Thermo Fisher
7.10.1 Thermo Fisher Corporate Summary
7.10.2 Thermo Fisher Business Overview
7.10.3 Thermo Fisher Companion Diagnostic Tests in Oncology Major Product Offerings
7.10.4 Thermo Fisher Companion Diagnostic Tests in Oncology Revenue in Global (2016-2021)
7.10.5 Thermo Fisher Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Companion Diagnostic Tests in Oncology Market Opportunities & Trends in Global Market
Table 2. Companion Diagnostic Tests in Oncology Market Drivers in Global Market
Table 3. Companion Diagnostic Tests in Oncology Market Restraints in Global Market
Table 4. Key Players of Companion Diagnostic Tests in Oncology in Global Market
Table 5. Top Companion Diagnostic Tests in Oncology Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Companion Diagnostic Tests in Oncology Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Companion Diagnostic Tests in Oncology Revenue Share by Companies, 2016-2021
Table 8. Global Companies Companion Diagnostic Tests in Oncology Product Type
Table 9. List of Global Tier 1 Companion Diagnostic Tests in Oncology Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Companion Diagnostic Tests in Oncology Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type